Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout

Wiley, Clinical Pharmacology & Therapeutics, 3(106), p. 652-660, 2019

Journal article published in 2019 by Daniel Hill‐McManus

, Scott Marshall, Elena Soto, Dyfrig A. Hughes

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by